NRX Pharmaceuticals, Inc. Income Tax Expense
NRX Pharmaceuticals, Inc. (NRXP) reported Income Tax Expense of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-14
- NRX Pharmaceuticals, Inc. income tax expense (benefit) for the quarter ending 2026-06-30 was $0.00.
- NRX Pharmaceuticals, Inc. income tax expense (benefit) for the quarter ending 2026-03-31 was $0.00.
- NRX Pharmaceuticals, Inc. income tax expense (benefit) for the quarter ending 2025-12-31 was $0.00.
- NRX Pharmaceuticals, Inc. income tax expense (benefit) for the quarter ending 2025-09-30 was $0.00.
- NRX Pharmaceuticals, Inc. income tax expense (benefit) for fiscal 2025 was $0.00.
- NRX Pharmaceuticals, Inc. income tax expense (benefit) for fiscal 2024 was $0.00.
- NRX Pharmaceuticals, Inc. income tax expense (benefit) for fiscal 2023 was $0.00.
- NRX Pharmaceuticals, Inc. income tax expense (benefit) for fiscal 2020 was $17.84K, a 78.81% decline from fiscal 2019.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month | Income Tax Expense (Benefit) 18 month | Income Tax Expense (Benefit) 21 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | $0.00 derived: sum of 3 quarters · filed 2026-08-14 | $0.00 derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-15 | $0.00 derived: sum of 2 quarters · filed 2026-05-15 | $0.00 derived: sum of 3 quarters · filed 2026-05-15 | $0.00 derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $0.00 derived: sum of 2 quarters · filed 2026-03-23 | $0.00 derived: sum of 3 quarters · filed 2026-08-14 | $0.00 10-K · filed 2026-03-23 | ||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2026-08-14 | $0.00 10-Q · filed 2025-11-14 | $0.00 derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | $0.00 derived: sum of 3 quarters · filed 2026-08-14 | $0.00 derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-15 | $0.00 derived: sum of 2 quarters · filed 2026-05-15 | $0.00 derived: sum of 3 quarters · filed 2026-05-15 | $0.00 derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $0.00 derived: sum of 2 quarters · filed 2026-03-23 | $0.00 derived: sum of 3 quarters · filed 2026-03-23 | $0.00 10-K · filed 2026-03-23 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2025-11-14 | $0.00 10-Q · filed 2025-11-14 | $0.00 derived: sum of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-18 | $0.00 10-Q · filed 2025-08-18 | $0.00 derived: sum of 3 quarters · filed 2025-08-18 | $0.00 derived: sum of 4 quarters · filed 2025-08-18 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-15 | $0.00 derived: sum of 2 quarters · filed 2025-05-15 | $0.00 derived: sum of 3 quarters · filed 2025-05-15 | $0.00 derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $0.00 derived: sum of 2 quarters · filed 2025-03-14 | $0.00 derived: sum of 3 quarters · filed 2025-03-14 | $0.00 10-K · filed 2025-03-14 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | $0.00 10-Q · filed 2023-11-14 | ||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $0.00 10-Q · filed 2024-08-14 | $0.00 10-Q · filed 2023-08-14 | |||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-14 | |||||
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-15 | $0.00 10-Q · filed 2022-08-15 | ||||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-16 | |||||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | -$5.36K derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-15 | $0.00 10-Q · filed 2022-08-15 | -$5.36K derived: sum of 3 quarters · filed 2022-08-15 | -$48.05K derived: sum of 4 quarters · filed 2022-08-15 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-16 | -$5.36K derived: sum of 2 quarters · filed 2022-05-16 | -$48.05K derived: sum of 3 quarters · filed 2022-05-16 | -$54.79K derived: sum of 4 quarters · filed 2022-05-16 | ||
| 2020-12-31 | -$5.36K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-14 | -$48.05K derived: sum of 2 quarters · filed 2021-05-14 | -$54.79K derived: sum of 3 quarters · filed 2021-05-14 | $17.84K 10-K/A · filed 2021-05-14 | ||
| 2020-09-30 | -$42.69K 10-Q · filed 2020-11-16 | -$49.43K derived: sum of 2 quarters · filed 2020-11-16 | $23.20K 10-Q · filed 2020-11-16 | $19.27K derived: sum of 4 quarters · filed 2021-05-21 | ||
| 2020-06-30 | -$6.74K 10-Q · filed 2020-08-14 | $65.89K 10-Q · filed 2020-08-14 | $61.97K derived: sum of 3 quarters · filed 2021-05-21 | $77.70K derived: sum of 4 quarters · filed 2021-05-21 | ||
| 2020-03-31 | $72.63K 10-Q · filed 2021-05-21 | $68.71K derived: sum of 2 quarters · filed 2021-05-21 | $84.44K derived: sum of 3 quarters · filed 2021-05-21 | $125.12K derived: sum of 4 quarters · filed 2021-05-21 | ||
| 2019-12-31 | -$3.92K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-14 | $11.81K derived: sum of 2 quarters · filed 2021-05-14 | $52.49K derived: sum of 3 quarters · filed 2021-05-14 | $84.21K 10-K/A · filed 2021-05-14 | ||
| 2019-09-30 | $15.74K 10-Q · filed 2020-11-16 | $56.41K derived: sum of 2 quarters · filed 2020-11-16 | $88.13K 10-Q · filed 2020-11-16 | $56.39K derived: sum of 4 quarters · filed 2020-11-16 | ||
| 2019-06-30 | $40.68K 10-Q · filed 2020-08-14 | $72.39K 10-Q · filed 2020-08-14 | $40.65K derived: sum of 3 quarters · filed 2020-08-14 | $75.64K derived: sum of 4 quarters · filed 2020-08-14 | ||
| 2019-03-31 | $31.72K 10-Q · filed 2020-05-15 | -$25.00 derived: sum of 2 quarters · filed 2020-05-15 | $34.96K derived: sum of 3 quarters · filed 2020-05-15 | $43.91K derived: sum of 4 quarters · filed 2020-05-15 | ||
| 2018-12-31 | -$31.74K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $3.25K derived: sum of 2 quarters · filed 2020-03-30 | $12.20K derived: sum of 3 quarters · filed 2020-03-30 | $16.31K 10-K · filed 2020-03-30 | ||
| 2018-09-30 | $34.99K 10-Q · filed 2019-11-14 | $43.94K derived: sum of 2 quarters · filed 2019-11-14 | $48.05K 10-Q · filed 2019-11-14 | $0.00 10-Q · filed 2018-11-08 | ||
| 2018-06-30 | $8.95K 10-Q · filed 2019-08-14 | $13.06K 10-Q · filed 2019-08-14 | $13.06K derived: sum of 3 quarters · filed 2019-08-14 | |||
| 2018-03-31 | $4.12K 10-Q · filed 2019-05-15 | $4.12K derived: sum of 2 quarters · filed 2019-05-15 | ||||
| 2017-12-31 | $0.00 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |